该研究也支持以前关于罗非考昔（Vioxx）与心血管副作用相关的结论。
The findings also support prior research linking rofecoxib (Vioxx) with adverse cardiovascular effects.
罗非考昔能显著增加腹泻和降低便秘、疲劳、发热、体重减轻、疼痛和止痛剂消耗发生率。
Rofecoxib significantly increased the incidence of diarrhoea and decreased constipation, fatigue, fever, weight loss, and pain, and analgesic consumption.
罗非考昔可提高患者治疗反应率和数个生活质量项目，包括疼痛相关项目和总的生活质量。
Rofecoxib improved response rate and several quality-of-life items, including pain-related items and global quality of life.
应用推荐